News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,749 Results
Type
Article (51765)
Company Profile (356)
Press Release (689628)
Multimedia
Podcasts (94)
Webinars (13)
Section
Business (213436)
Career Advice (2140)
Deals (36625)
Drug Delivery (107)
Drug Development (84303)
Employer Resources (178)
FDA (16962)
Job Trends (15435)
News (360108)
Policy (33914)
Tag
Academia (2832)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (89)
Alliances (52999)
ALS (96)
Alzheimer's disease (1423)
Antibody-drug conjugate (ADC) (150)
Approvals (16950)
Artificial intelligence (289)
Autoimmune disease (25)
Automation (16)
Bankruptcy (368)
Best Places to Work (12013)
BIOSECURE Act (20)
Biosimilars (109)
Biotechnology (254)
Bladder cancer (83)
Brain cancer (28)
Breast cancer (290)
Cancer (2386)
Cardiovascular disease (181)
Career advice (1790)
Career pathing (31)
CAR-T (170)
Cell therapy (477)
Cervical cancer (20)
Clinical research (68116)
Collaboration (880)
Company closure (1)
Compensation (540)
Complete response letters (24)
COVID-19 (2745)
CRISPR (47)
C-suite (256)
Cystic fibrosis (105)
Data (2247)
Decentralized trials (2)
Denatured (35)
Depression (47)
Diabetes (275)
Diagnostics (6704)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (129)
Drug pricing (108)
Drug shortages (27)
Duchenne muscular dystrophy (96)
Earnings (88656)
Editorial (41)
Employer branding (22)
Employer resources (153)
Events (118557)
Executive appointments (751)
FDA (18263)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (792)
Gene editing (117)
Generative AI (26)
Gene therapy (339)
GLP-1 (746)
Government (4593)
Grass and pollen (5)
Guidances (67)
Healthcare (19732)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (130)
Indications (30)
Infectious disease (2892)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (100)
Interviews (335)
IPO (16954)
IRA (41)
Job creations (3857)
Job search strategy (1519)
Kidney cancer (11)
Labor market (38)
Layoffs (500)
Leadership (18)
Legal (8213)
Liver cancer (80)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (62)
Manufacturing (326)
MASH (69)
Medical device (14144)
Medtech (14149)
Mergers & acquisitions (20229)
Metabolic disorders (713)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (99)
Neuropsychiatric disorders (29)
Neuroscience (1989)
NextGen: Class of 2025 (6939)
Non-profit (4679)
Now hiring (39)
Obesity (378)
Opinion (224)
Ovarian cancer (77)
Pain (88)
Pancreatic cancer (85)
Parkinson's disease (154)
Partnered (21)
Patents (244)
Patient recruitment (115)
Peanut (49)
People (59968)
Pharmaceutical (75)
Pharmacy benefit managers (18)
Phase I (21437)
Phase II (29956)
Phase III (22237)
Pipeline (1233)
Policy (145)
Postmarket research (2645)
Preclinical (9427)
Press Release (71)
Prostate cancer (110)
Psychedelics (33)
Radiopharmaceuticals (266)
Rare diseases (403)
Real estate (6308)
Recruiting (67)
Regulatory (23271)
Reports (46)
Research institute (2546)
Resumes & cover letters (369)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (74)
Series A (141)
Series B (87)
Service/supplier (15)
Sickle cell disease (58)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (31)
Startups (3882)
State (2)
Stomach cancer (16)
Supply chain (70)
Tariffs (40)
The Weekly (57)
Vaccines (746)
Venture capitalists (42)
Weight loss (252)
Women's health (38)
Worklife (16)
Date
Last 7 days (926)
Last 30 days (2562)
Last 365 days (33861)
2025 (11172)
2024 (36637)
2023 (41500)
2022 (52824)
2021 (57456)
2020 (56049)
2019 (48868)
2018 (36853)
2017 (34053)
2016 (33732)
2015 (39899)
2014 (33529)
2013 (29024)
2012 (31215)
2011 (31627)
2010 (29628)
Location
Africa (786)
Alabama (54)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (41580)
Australia (7041)
California (6294)
Canada (2039)
China (545)
Colorado (273)
Connecticut (287)
Delaware (157)
Europe (92002)
Florida (924)
Georgia (216)
Idaho (61)
Illinois (566)
India (26)
Indiana (316)
Iowa (11)
Japan (167)
Kansas (109)
Kentucky (26)
Louisiana (11)
Maine (70)
Maryland (918)
Massachusetts (4783)
Michigan (241)
Minnesota (403)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (26)
Nevada (64)
New Hampshire (69)
New Jersey (1767)
New Mexico (30)
New York (1787)
North Carolina (1031)
North Dakota (9)
Northern California (2726)
Ohio (209)
Oklahoma (15)
Oregon (37)
Pennsylvania (1402)
Puerto Rico (13)
Rhode Island (34)
South America (1191)
South Carolina (23)
South Dakota (1)
Southern California (2354)
Tennessee (103)
Texas (937)
United States (23921)
Utah (187)
Virginia (151)
Washington D.C. (63)
Washington State (572)
West Virginia (3)
Wisconsin (57)
741,749 Results for "stemedica cell technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Unlocking the Future of Personalized Medicine with iPS Cell Technology
April 24, 2025
·
3 min read
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
March 17, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
Press Releases
Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology
March 26, 2025
·
3 min read
Press Releases
Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer
April 17, 2025
·
2 min read
Press Releases
Cellares’ Cell Shuttle™ Receives FDA Advanced Manufacturing Technology (AMT) Designation for Automated Cell Therapy Manufacturing
April 1, 2025
·
3 min read
FDA
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that Marks’ legacy will carry on.
April 28, 2025
·
7 min read
·
Heather McKenzie
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease
March 27, 2025
·
8 min read
1 of 74,175
Next
